Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
IMUNON Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
-
Sandoz Canada achieves carbon neutral certification for its commercial operations
-
Kornit Digital Empowers Hybrid Digital to Fuel its Next Stage of Business Growth
-
Tacos with a Purpose from Taco Bueno Raises Over $100,000 for Domestic Violence Support Organizations in Texas and Oklahoma
-
Cerence Appoints Brian Krzanich as Chief Executive Officer
-
NV5 to Host Third Quarter 2024 Conference Call on Wednesday, October 30th at 4:30pm ET
-
Sofwave Obtains U.S. Patent for Fat Tissue Reduction Technology
-
Nusano Presenting at Industry Events in October
-
BC Real Estate Association Urges Comprehensive Review of BC Housing Taxes
-
Total Energy Services Inc. Announces 2024 Third Quarter Conference Call and Webcast
-
NMI Holdings, Inc. Announces S&P Rating Upgrades
-
Beanfield Leverages DZS Velocity Technology to Bring Up to 8 Gig Broadband Speeds to Canadian MDUs
-
Toronto Hosts its Fourth Annual Refugee Hiring Event Connecting 600 Refugees with Top Employers
-
Bionomics Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision
-
Vortex Energy Completes Phase 1 Exploration at the Fire Eye Uranium Property, Saskatchewan and Amends Option Terms
-
Alternative Ventures LLC Secures Exclusive $96M Distribution Agreement with DXD Distributors for It's Brand PRESS'D
-
Poka Lambro Deploys Infinera to Expand Its Middle-mile Network and Increase West Texas Communities’ Opportunity and Competitiveness
-
Worksport Ltd. Announces Strategic Updates and Upcoming Product Launches
-
VERSES Provides Q3 2024 Corporate Update
-
Yuanyu Enterprise Management announces entry into an exclusive license agreement for its innovative matchmaking technology covering the UK and Europe
-
Alternative Ventures LLC Secures Exclusive $96M Distribution Agreement with DXD Distributors for It's Brand PRESS'D
-
TradFi Veteran Shunyet Jan Joins Bybit as New Head of Derivatives Business
-
Haoxi Health Technology Limited Announces Preliminary Unaudited FY24 Financial Results with projected 72% Revenue Growth
-
Duos Edge AI Partners with Accu-Tech To Deploy Edge Data Centers
-
NMI Holdings, Inc. Announces S&P Rating Upgrades
-
Golden Matrix Group to Showcase Expanded Portfolio and Proprietary Technology at G2E Las Vegas 2024
-
Insignis Therapeutics Announces Positive Results from Phase 1 Clinical Study of IN-001 Liquid Epinephrine Sublingual Spray for Anaphylaxis
-
Nuvectis Pharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
-
Wearable Devices Ltd. Announces 1-for-20 Reverse Stock Split
-
PodcastOne (PODC) Appoints Jim Lally Head of Business Development
-
VisiConsult and Glimpse Partner to Launch a High-Resolution, Seconds-Long Full-Cell Scanning Capability for the Battery Industry
-
AFC Gamma Provides Story of Maryland with $41 Million Senior Secured Credit Facility
-
Monopar Initiates Clinical Trial of Novel uPAR-Targeted Radiopharmaceutical Therapy in Advanced Cancers
-
Ultragenyx Receives Breakthrough Therapy Designation for Setrusumab (UX143) in Osteogenesis Imperfecta
-
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
Kratos and Radisys Partner on Cloud Native 5G-NTN OpenSpace® Solutions to Enable Seamless Satellite Access for Terrestrial Networks
-
Bazaarvoice Announces Industry’s First Integrated Social Content Solution, Bazaarvoice Vibe
-
Akoya’s Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy
-
NIP Group Announces Appointment of New Independent Director
-
Magnite to Announce Third Quarter 2024 Financial Results on November 7, 2024
-
Heliene Partners With Transition Equity Partners to Expand Domestic Solar Manufacturing Capacity
-
ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program
-
Gabelli Funds to Host 48th Annual Automotive Symposium at The Encore at Wynn, Las Vegas, Nevada
-
Inspire Medical Systems, Inc. to Report Third Quarter 2024 Financial Results on November 4, 2024
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium
-
ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society
-
Dark Horse Consulting Launches Initiative for Certification of Manufacturing Capabilities
-
ZyVersa Therapeutics Forms New Scientific Advisory Board to Support Development of Inflammasome ASC Inhibitor IC 100 for Obesity with Metabolic Complications
-
Taco John’s Taps Kevin Flaherty as its Chief Marketing Officer
